Louis Vuitton owner LVMH reported disappointing results and said it faced challenges in most markets. Shares of both the ...

Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat ...

A rape carried out relatively quickly cannot be considered an attenuating factor in sentencing decisions, Switzerland's highest court has said, after one of its previous rulings suggesting the ...

UK Prime Minister Keir Starmer on Wednesday called for the jailed Hong Kong media tycoon Jimmy Lai to be freed from prison, as the pro-democracy campaigner faces trial.

ASML extends losses after cutting sales guidance, Nvidia stock edges higher, and third-quarter earnings at Morgan Stanley top ...

Optune Lua creates tumor treating fields to disrupt cancer cell division, and it is used in conjunction with PD-1/PD-L1 ...

On October 15th, NovoCure Limited received FDA approval of its lung cancer treatment. Read why I upgrade NVCR stock from buy ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Following promising results from the phase 3 LUNAR trial, the FDA has approved Optune Lua for use with PD-1/PD-L1 inhibitors ...

S&P 500 and Nasdaq 100 futures steady amid tech losses. Morgan Stanley beats Q3 estimates, up 3%, and Cisco climbs 2% on AI ...

The FDA yesterday the approval of Novocure’s Optune device to include the treatment of metastatic non-small cell lung cancer.